Kiniksa Pharmaceuticals International, PLC (KNSA) — DEFA14A Filings
All DEFA14A filings from Kiniksa Pharmaceuticals International, PLC. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (3)
-
Kiniksa Pharma Files 2025 Proxy Statement
— May 28, 2025 Risk: low
Kiniksa Pharmaceuticals International, plc filed a Definitive Proxy Statement (DEFA14A) on May 28, 2025, for its 2025 Annual Meeting of Shareholders. The filing -
Kiniksa Pharma Files Proxy Materials
— May 9, 2025 Risk: low
Kiniksa Pharmaceuticals International, plc filed a Definitive Additional Materials proxy statement on May 9, 2025. This filing relates to the company's proxy ma -
Kiniksa Pharma Files Proxy Statement for Shareholder Meeting
— May 29, 2024 Risk: low
Kiniksa Pharmaceuticals, Ltd. filed a Definitive Proxy Statement (DEFA14A) on May 29, 2024, related to a Special Court-Ordered Meeting of Shareholders. The fili
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX